Weekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing

Thursday, June 28, 2018

Continue Reading

Sapphire Technology Completes a Nationwide Distribution Agreement With Burkhart Dental Supply

Wednesday, June 27, 2018

Denver-based dental instrument company, Sapphire Technology, recently completed a nationwide distribution agreement with Burkhart Dental Supply (Tacoma, WA). Burkhart will soon market and sell Sapphire’s innovative and proprietary line of SGS® sapphire-tipped composite dental instruments. Established in 1888, Burkhart is one of the oldest and most established distributors of dental products. The SGS® instruments are intended to work correctly and ideally with dental restorations employing composite resin restoration materials – now the most prevalent dental restoration material. In addition to acquiring Burkhart as a distributor, Sapphire received a European Patent for its dental instruments. Sapphire was also issued a 2nd US patent.  

New Office Location Helps Packaging Compliance Labs Accelerate Growth In Healthcare Packaging

Monday, June 25, 2018

Packaging Compliance Labs, a top medical device and pharmaceutical packaging engineering and validation firm, recently opened a new office in the heart of downtown Denver, Colorado, to accommodate rapid growth and leverage the area’s growing biotechnology industry.  

Weekly Policy Update: FDA Releases Important Guidances

Thursday, June 21, 2018

The FDA recently announced the release of important guidances, “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities–Questions and Answers,” and “Medical Product Communications That Are Consistent With the FDA-Required Labeling”. The first guidance answers common questions about companies’ communications to payors, including insurance companies, formulary committees and similar entities. The second guidance provides the FDA’s views on manufacturers’ communication of information that is not contained in the FDA-required labeling for their products, but that is consistent with that labeling. Both guidances are critical to outline how companies can communicate off-label health care economic information about their products to health plans, hospitals and other drug purchasers.  

Weekly Policy Update: Drug Pricing News

Friday, June 15, 2018

This week HHS Secretary Alex Azar appeared in front of the Senate Health, Education, Labor and Pensions Committee for a hearing on drug pricing. Secretary Azar’s prepared testimony in large part summarized President Trump’s blue print. For more information on the blueprint click here and to view the full hearing click here

Colorado BioScience Association Highlights Innovative Spirit, Collaborative Culture in Colorado

Wednesday, June 13, 2018

Annual Bioscience Colorado Magazine Profiles Leaders, Incubators and Ecosystems 
Continue Reading

Weekly Policy Update: BIO International Convention

Friday, June 08, 2018

This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to meet with CBSA member companies, industry partners, and other bioscience supporters. The convention also provides a venue where we can learn directly from industry leaders and share policy lessons, trends and insights.  

Colorado BioScience Association Congratulates Researchers Honored with Boettcher Foundation Webb-Waring Awards

Thursday, June 07, 2018

Seven biomedical researchers at Colorado’s top research institutions have been selected to receive $1.41 million in total funding from the Boettcher Foundation’s Webb-Waring Biomedical Research Awards program.  

National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth

Tuesday, June 05, 2018

A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry has held a leading position as an economic driver and job generator. 

Weekly Policy Update: BIO International Convention and Voter Registration

Friday, June 01, 2018

Continue Reading